| Autor: |
Cooper, Lauren, DeVore, Adam, Cowger, Jennifer, Pinney, Sean, Baran, David, DeWald, Tracy A., Burt, Tara, Pietzsch, Jan B., Walton, Antony, Aaronson, Keith, Shah, Palak |
| Předmět: |
|
| Zdroj: |
Clinical Cardiology; Oct2023, Vol. 46 Issue 10, p1163-1172, 10p |
| Abstrakt: |
Introduction: Approximately 1/3 of patients with acute decompensated heart failure (ADHF) are discharged with persistent congestion. Worsening renal function (WRF) occurs in approximately 50% of patients hospitalized for ADHF and the combination of WRF and persistent congestion are associated with higher risk of mortality and HF readmissions. Methods: We designed a multicenter, prospective registry to describe current treatments and outcomes for patients hospitalized with ADHF complicated by WRF (defined as a creatinine increase ≥0.3 mg/dL) and persistent congestion at 96 h. Study participants were followed during the hospitalization and through 90‐day post‐discharge. Hospitalization costs were analyzed in an economic substudy. Results: We enrolled 237 patients hospitalized with ADHF, who also had WRF and persistent congestion. Among these, the average age was 66 ± 13 years and 61% had a left ventricular ejection fraction (LVEF) ≤ 40%. Mean baseline creatinine was 1.7 ± 0.7 mg/dL. Patients with persistent congestion had a high burden of clinical events during the index hospitalization (7.6% intensive care unit transfer, 2.1% intubation, 1.7% left ventricular assist device implantation, and 0.8% dialysis). At 90‐day follow‐up, 33% of patients were readmitted for ADHF or died. Outcomes and costs were similar between patients with reduced and preserved LVEF. Conclusions: Many patients admitted with ADHF have WRF and persistent congestion despite diuresis and are at high risk for adverse events during hospitalization and early follow‐up. Novel treatment strategies are urgently needed for this high‐risk population. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text